Epithelial-Macrophage Crosstalk in COPD: Emerging Mechanisms of Inflammation and Pyroptosis.

Save

Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation, with chronic inflammation contributing to progressive lung damage and impaired pulmonary function. Although cigarette smoking is a principal risk factor, the molecular mechanisms linking cigarette smoke exposure to sustained immune activation remain incompletely understood. Increasing evidence indicates that interactions between airway epithelial cells and immune cells play critical roles in COPD pathogenesis (1).

In 2024, Wang et al. (2) published an original research article in Immune Network investigating the role of airway epithelial cell-derived exosomal long non-coding RNA maternally expressed gene 3 (MEG3) in cigarette smoke-induced pulmonary inflammation. Notably, this study has been highly cited within 2 years of publication.

Its findings are relevant to several important research areas, including cigarette smoke-induced pulmonary inflammation, extracellular vesicle-mediated immune regulation, non-coding RNA signaling, and inflammatory cell death.

Exosomal MEG3 and Epithelial–Macrophage Communication

A major contribution of this study is the identification of a molecular pathway linking cigarette smoke-exposed airway epithelial cells to macrophage inflammatory responses. Beyond their barrier function, airway epithelial cells actively participate in pulmonary immune responses by releasing soluble mediators and extracellular vesicles that influence neighboring immune cells. Previous studies have highlighted the involvement of extracellular vesicles in macrophage polarization, inflammatory signaling, and intercellular communication in COPD (3).

Using exosomes isolated from cigarette smoke extract-exposed mouse airway epithelial cells, Wang et al. (2) identified a mechanism through which epithelial cell-derived signals enhance inflammatory macrophage polarization and pyroptotic responses. Importantly, they identified MEG3, a long non-coding RNA, as a key mediator of these effects.

Suppression of MEG3 attenuated inflammatory macrophage activation and pyroptosis, supporting its functional involvement in cigarette smoke-induced pulmonary inflammation. These findings highlight exosomal non-coding RNAs as potential regulators of epithelial–immune cell communication in chronic inflammatory diseases.

The MEG3–SPI1–METTL3–TREM-1 Signaling Axis

Another important contribution is the proposed molecular mechanism linking exosomal MEG3 to macrophage activation. Wang et al. (2) reported that MEG3 promotes spleen focus forming virus proviral integration oncogene (SPI1)-dependent methyltransferase 3 (METTL3) expression, leading to increased N6-methyladenosine (m6A) modification of triggering receptor expressed on myeloid cells 1 (TREM-1) RNA and enhanced TREM-1 expression.

TREM-1 enhances inflammatory responses in myeloid cells and has been implicated in the amplification of innate immune signaling (4). In addition, m6A RNA modification has emerged as an important regulator of immune recognition, inflammatory responses, and immune cell function (5).

By connecting MEG3, SPI1, METTL3, and TREM-1, the study proposes a mechanistic link between non-coding RNA regulation, epitranscriptomic modification, and innate immune activation. This pathway may provide a basis for investigating related inflammatory mechanisms beyond COPD, although its broader biological relevance remains to be established.

Pyroptosis and Pulmonary Inflammation

Pyroptosis is a form of inflammatory cell death characterized by gasdermin-mediated membrane permeabilization and the release of intracellular inflammatory mediators. The discovery that inflammatory caspases activate gasdermin D provided a molecular explanation for the execution of pyroptotic cell death (6). Wang et al.

(2) reported that exosomal MEG3 enhances the expression of inflammasome- and pyroptosis-associated proteins, including NOD-like receptor family pyrin domain containing 3, caspase-1, and gasdermin D (2). Their experiments in cigarette smoke-exposed mice further supported the involvement of this pathway in pulmonary inflammation and tissue injury.

These observations are noteworthy because they integrate epithelial–macrophage communication, inflammatory macrophage polarization, and pyroptosis within a common molecular framework. Such interactions may contribute to the amplification and persistence of inflammatory responses in COPD.

Scientific Impact and Future Perspectives

The MEG3–SPI1–METTL3–TREM-1 signaling pathway proposed by Wang et al. (2) provides a potentially important framework for understanding how environmental exposures influence immune cell behavior through extracellular RNA signaling. The study connects several rapidly developing areas of immunology, including extracellular vesicle biology, RNA epigenetics, innate immune activation, and inflammatory cell death.

The broader relevance of extracellular vesicles to COPD pathogenesis, biomarker development, and therapeutic strategies has also been emphasized in recent reviews (7).

Nevertheless, several important questions remain. First, the proposed pathway requires further validation in human airway epithelial cells, primary macrophages, and clinical specimens from patients with COPD. Second, the relative contribution of exosomal MEG3 should be evaluated alongside other inflammatory mediators and extracellular vesicle cargoes.

Third, the therapeutic potential of targeting MEG3, METTL3, or TREM-1 should be investigated while considering possible effects on essential host-defense mechanisms.

It will also be important to determine whether exosomal MEG3 levels correlate with COPD severity, inflammatory phenotypes, or disease exacerbations. Such studies may help establish its potential clinical relevance as a biomarker or therapeutic target. Moreover, investigations into whether this regulatory pathway operates in other inflammatory conditions could clarify its broader significance in immune regulation.

Concluding Remarks

The study by Wang et al. (2) provides valuable insights into the molecular mechanisms underlying cigarette smoke-induced pulmonary inflammation. By linking epithelial cell-derived exosomal MEG3 to macrophage polarization, m6A-associated TREM-1 regulation, and pyroptosis, it offers an integrated perspective on immune dysregulation in COPD.

The impressive number of citations this article has received reflects the considerable interest it has generated within the scientific community. Nevertheless, further validation, particularly in human studies, will be essential to determine whether the proposed signaling pathway can ultimately support new diagnostic or therapeutic strategies for COPD.

Related articles

PubMed

Validation of a prognostic model for chronic obstructive pulmonary disease (COPD) and evaluation of methods to include related data.

Background and objectives Prognostic models estimate a patient’s individual risk of future health outcomes using clinical and demographic data, supporting treatment planning. Such models are particularly useful for chronic diseases, where predicting disease progression can help guide interventions and improve patient outcomes. In chronic obstructive pulmonary disease (COPD), several models have been developed to predict long-term mortality risk. However, these models are often trained on patien...

PubMed

Sleep in COPD: an understudied and clinically important issue.

This review provides an overview of objective and subjective sleep characteristics in the general chronic obstructive pulmonary disease (COPD) population and discusses associations with airway symptoms, psychological factors, quality of life, and common sleep disorders. Available studies indicate that patients with COPD often exhibit altered sleep architecture, including increased light sleep, reduced slow-wave and rapid eye movement (REM) sleep, frequent arousals, reduced sleep efficiency, and...